Results 171 to 180 of about 91,755 (270)
Figure 6 Comprehensive genomic profiling identified additional actionable alterations in a substantial proportion of patients with non‐squamous NSCLC despite previously identified driver alterations, with some findings leading to subsequent matched targeted therapies.
Yoshihiro Masui +15 more
wiley +1 more source
Association of Cachexia-Related Status With Treatment Outcomes in Advanced Gastric Cancer Receiving First-Line Therapy With or Without Nivolumab. [PDF]
Fujii H +12 more
europepmc +1 more source
Summary Background and objectives Systemic treatment of cutaneous melanoma has changed since 2011, with clinical studies demonstrating improved outcomes. This analysis evaluated whether this improvement is evident in a real‐world cohort, focusing on overall survival (OS) and relapse‐free survival (RFS).
Lena Nanz +7 more
wiley +1 more source
Comparative Evaluation of the Effectiveness of Nivolumab Versus Axitinib in the Second-Line Treatment of Patients with Metastatic Renal Cell Carcinoma: A Two-Center Experience. [PDF]
Buğday İ +4 more
europepmc +1 more source
Summary Background Recent therapeutic advances, such as tebentafusp, may prolong survival of metastatic uveal melanoma (mUM) patients. Early detection of metastases during follow‐up (FU) may be clinically relevant; however, FU remains non‐standardized.
Susanne Dugas‐Breit +10 more
wiley +1 more source
Beyond PD-L1 and HER2: emerging predictive biomarkers in gastroesophageal tumors. [PDF]
Alsina M +2 more
europepmc +1 more source
The CALLY Index for Unresectable or Recurrent Gastric Cancer Treated With Nivolumab: A Multicenter Retrospective Study. [PDF]
Takeshita K +9 more
europepmc +1 more source
ABSTRACT Objectives The MYLENE non‐interventional study (NIS) aimed to close the gap in real‐world data on the experience and satisfaction with subcutaneous (sc) and intravenous (iv) daratumumab application in patients with newly diagnosed non‐transplant eligible multiple myeloma in Germany.
Eyck von der Heyde +9 more
wiley +1 more source
Immunotherapy in Advanced Epithelial Ovarian Cancer: Successes and Frustrations. [PDF]
Marshall LA +3 more
europepmc +1 more source
Patients with severe ICI‐induced liver injury are commonly treated with corticosteroids, but the optimal tapering strategy remains uncertain. In this study, a gradual corticosteroid tapering strategy based partly on Japanese clinical practice for autoimmune hepatitis was associated with a low rate of relapse and enabled many patients to safely resume ...
Naoto Soma +7 more
wiley +1 more source

